Form 4: LeMaitre Vascular CFO LeBlanc Reports Acquisition of Dividend Equivalent Rights

Chief Financial Officer Dorian Paul LeBlanc reports the acquisition of dividend equivalent rights related to a restricted stock unit award.

Summary

• Dorian Paul LeBlanc, CFO of LeMaitre Vascular Inc. [LMAT], reported the acquisition of 2.91 dividend equivalent rights on March 27, 2025.
• These rights are associated with a restricted stock unit award granted on March 10, 2025, and vest proportionately with the award.
• Each dividend equivalent right represents the economic equivalent of one share of LeMaitre Vascular's common stock.
• Following the transaction, LeBlanc directly owns 2.91 dividend equivalent rights.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a routine disclosure of dividend equivalent rights acquisition, a standard part of executive compensation.

Industry Context

This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It provides transparency regarding the alignment of executive interests with shareholder value through equity-based compensation.

Stakeholder Impact

• The acquisition of dividend equivalent rights aligns the CFO's interests with those of shareholders, as the value of these rights is tied to the performance of the company's stock.

Key Dates

Keywords

Form 4, Dividend Equivalent Rights, LeMaitre Vascular, LMAT, Dorian Paul LeBlanc, CFO, Insider Trading